Literature DB >> 9057742

Miltefosine in recurrent cutaneous breast cancer.

S Clive, R C Leonard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9057742     DOI： 10.1016/S0140-6736(05)61570-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.

Authors:  Y Le Fichoux; D Rousseau; B Ferrua; S Ruette; A Lelièvre; D Grousson; J Kubar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

2.  Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer.

Authors:  J M Terwogt; I A Mandjes; H Sindermann; J H Beijnen; W W ten Bokkel Huinink
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

3.  Computational identification of potential chemoprophylactic agents according to dynamic behavior of peroxisome proliferator-activated receptor gamma.

Authors:  Zhiwei Yang; Yizhen Zhao; Dongxiao Hao; He Wang; Shengqing Li; Lintao Jia; Xiaohui Yuan; Lei Zhang; Lingjie Meng; Shengli Zhang
Journal:  RSC Adv       Date:  2020-12-22       Impact factor: 3.361
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.